Facebooktwitterlinkedin
     
Parenteral Portfolio

Private Label

OTC Topicals

Product launch and trademark registration of CMS- Inj.®

Written by on . Posted in

Asepsis Pharmaceuticals, Inc. announces the trademark registration of CMS- Inj.®  Colistimethate Sodium for Injection (USP) in 1 MIU and 2 MIU Vials.

  • Share Us
    • Facebooktwitterlinkedin

    Leave a comment

    You must be logged in to post a comment.

    USA

    Asepsis Pharmaceuticals Inc.
    1584 Independence Blvd.
    Sarasota, FL 34234
    United States
    Tel: +1 888-608-8884
    Fax: +1 888-608-8885
    info@asepsispharma.com

    Mexico

    Asepsis Pharma SA de CV
    La Polar #6 DEPTO1 Colonial Del.
    Gustavo A Madero C.P. 07800
    Mexico D.F.
    Tel: +52 (55) 5750-3516
    Fax: +52 (55) 2789-5706
    info@asepsispharma.com

    India

    Asepsis Pharmaceuticals Pvt. Ltd.
    226, Patel Center, Sainath
    Road Malad West
    Mumbai
    Tel: +91 22 2844 2942
    Fax: +91 22 6645 9822
    info@asepsispharma.com

    China

    Asepsis Pharmaceuticals Ltd.
    12 F Merrit Industrial
    Center Kowloon,
    Hong Kong
    Tel: +852 9018 2393
    Fax: +852 3010 1873
    info@asepsispharma.com